All examsPTCB / PTCEFoundation path
View coverage
FREE ORIGINAL PRACTICE · ANSWERS & EXPLANATIONS

PTCB / PTCE Practice Questions & Answers

Practise original pharmacy processing cases and exact calculations using explicit training data.

Read 10 original sample questions with worked explanations before opening the practice studio. These examples introduce selected topics from this PTCB / PTCE foundation path.

Free access · No sign-up · No personal progress recorded on this page

What this practice covers

PTCE2026 medication-information, federal-workflow, safety and order-processing foundations

200 original four-choice learning items in51families, including33exact training calculations. Not a full timed PTCE replica.

10 public examples200 question variants in the studio51 task families

Review status: Independent educator review and learner calibration are pending. Use these selected foundation examples alongside the coverage map and current official references.

Check the coverage map and remaining gaps
CHOOSE A STARTING POINT

Topics in this foundation path

The examples below span 4 of 4 learning domains. Counts describe the current catalog, not the exam's official weighting.

TRY A QUESTION. FOLLOW THE REASONING.

Sample questions with answers

Work out your answer first, then compare the explanation. This stable selection uses distinct task families across the available learning domains.

QUESTION 01Medications

Drug identity and label fields

An example label names acetaminophen as the substance in the product. Which field is this?

  1. Strength
  2. Active ingredient
  3. Dosage form
  4. Route

Answer: Active ingredient

  1. The named substance is the active ingredient.
  2. The active ingredient identifies the drug substance.
  3. The matching choice isActive ingredient. Compare the actual requested field or workflow stage with each alternative rather than choosing a generally related statement.
Compare the other answer choices
Strength

Strength gives the amount of drug per stated unit. The given case instead establishes:The named substance is the active ingredient.

Dosage form

Dosage form describes the physical pharmaceutical preparation. The given case instead establishes:The named substance is the active ingredient.

Route

Route describes the intended pathway of administration. The given case instead establishes:The named substance is the active ingredient.

Reference basis: PTCE Content Outline effective January6,2026. These are original learning questions, not questions reproduced from the references.

QUESTION 02Federal Requirements

Controlled substances and restricted processing

Using the current DEA scheduling reference, which federal schedule contains oxycodone?

  1. Schedule III
  2. Schedule IV
  3. Schedule V
  4. Schedule II

Answer: Schedule II

  1. Oxycodone is listed in ScheduleII.
  2. The DEA reference lists oxycodone as ScheduleII.
  3. The matching choice isSchedule II. Compare the actual requested field or workflow stage with each alternative rather than choosing a generally related statement.
Compare the other answer choices
Schedule III

The DEA reference lists ketamine as ScheduleIII. The given case instead establishes:Oxycodone is listed in ScheduleII.

Schedule IV

The DEA reference lists alprazolam, including Xanax, as ScheduleIV. The given case instead establishes:Oxycodone is listed in ScheduleII.

Schedule V

The DEA reference lists pregabalin, including Lyrica, as ScheduleV. The given case instead establishes:Oxycodone is listed in ScheduleII.

Reference basis: PTCE Content Outline effective January6,2026; DEA Drug Scheduling reference. These are original learning questions, not questions reproduced from the references.

QUESTION 03Patient Safety and Quality Assurance

Patient and product safety checks

An otherwise correct prescription is prepared under another person record. Which error category is present?

  1. Wrong drug
  2. Wrong dosage form
  3. Wrong strength
  4. Wrong patient

Answer: Wrong patient

  1. The product can match the order while the patient identity is wrong.
  2. Patient identity must match the intended order and record.
  3. The matching choice isWrong patient. Compare the actual requested field or workflow stage with each alternative rather than choosing a generally related statement.
Compare the other answer choices
Wrong drug

The selected active substance must match the order. The given case instead establishes:The product can match the order while the patient identity is wrong.

Wrong strength

The amount per dosage unit must match. The given case instead establishes:The product can match the order while the patient identity is wrong.

Wrong dosage form

The formulation must match the intended product. The given case instead establishes:The product can match the order while the patient identity is wrong.

Reference basis: PTCE Content Outline effective January6,2026. These are original learning questions, not questions reproduced from the references.

QUESTION 04Order Entry and Processing

Order fields, identifiers and stock status

A training direction says take2tablets at each administration. Which quantity is2tablets?

  1. Frequency
  2. Days supply
  3. Dose per administration
  4. Total quantity supplied

Answer: Dose per administration

  1. The value is the amount used at one administration.
  2. Dose states the amount used at one administration.
  3. The matching choice isDose per administration. Compare the actual requested field or workflow stage with each alternative rather than choosing a generally related statement.
Compare the other answer choices
Frequency

Frequency states how often an administration occurs. The given case instead establishes:The value is the amount used at one administration.

Total quantity supplied

Quantity states the number or amount supplied. The given case instead establishes:The value is the amount used at one administration.

Days supply

Days supply estimates how long the supplied amount lasts under explicit directions. The given case instead establishes:The value is the amount used at one administration.

Reference basis: PTCE Content Outline effective January6,2026. These are original learning questions, not questions reproduced from the references.

QUESTION 05Medications

Formulation and administration labels

An example product is labeled for administration to the eye. Which route term matches?

  1. Otic
  2. Topical
  3. Oral
  4. Ophthalmic

Answer: Ophthalmic

  1. The relevant anatomical site is the eye.
  2. Ophthalmic means intended for the eye.
  3. The matching choice isOphthalmic. Compare the actual requested field or workflow stage with each alternative rather than choosing a generally related statement.
Compare the other answer choices
Otic

Otic means intended for the ear. The given case instead establishes:The relevant anatomical site is the eye.

Topical

Topical describes application to a body surface as directed. The given case instead establishes:The relevant anatomical site is the eye.

Oral

Oral describes administration by mouth. The given case instead establishes:The relevant anatomical site is the eye.

Reference basis: PTCE Content Outline effective January6,2026. These are original learning questions, not questions reproduced from the references.

QUESTION 06Federal Requirements

Recalls, tracing, and disposition

An FDA notice states reasonable probability of serious adverse health consequences or death. Which class definition matches?

  1. Class I
  2. Class III
  3. No FDA recall classification can be inferred from the supplied facts alone
  4. Class II

Answer: Class I

  1. The serious-consequence probability matches the FDA ClassI definition.
  2. ClassI involves reasonable probability of serious adverse health consequences or death.
  3. The matching choice isClass I. Compare the actual requested field or workflow stage with each alternative rather than choosing a generally related statement.
Compare the other answer choices
Class II

ClassII involves temporary or medically reversible effects or remote probability of serious consequences. The given case instead establishes:The serious-consequence probability matches the FDA ClassI definition.

Class III

ClassIII involves a violation not likely to cause adverse health consequences. The given case instead establishes:The serious-consequence probability matches the FDA ClassI definition.

No FDA recall classification can be inferred from the supplied facts alone

A concern without an assigned classification or sufficient risk information cannot be independently classified by a technician. The given case instead establishes:The serious-consequence probability matches the FDA ClassI definition.

Reference basis: PTCE Content Outline effective January6,2026; FDA Recalls Background and Definitions. These are original learning questions, not questions reproduced from the references.

QUESTION 07Patient Safety and Quality Assurance

Near misses, errors, and improvement

A wrong product is selected but the final check catches it before the patient receives it. Which stage is this?

  1. Near miss caught before reaching the patient
  2. Error that reached the patient
  3. A system hazard without a completed error
  4. A reported adverse effect needing evaluation

Answer: Near miss caught before reaching the patient

  1. The mismatch was intercepted before reaching the patient.
  2. A near miss is intercepted before reaching the patient.
  3. The matching choice isNear miss caught before reaching the patient. Compare the actual requested field or workflow stage with each alternative rather than choosing a generally related statement.
Compare the other answer choices
Error that reached the patient

An error can reach a patient even if no harm is yet apparent. The given case instead establishes:The mismatch was intercepted before reaching the patient.

A reported adverse effect needing evaluation

An unwanted effect needs evaluation and may not establish a dispensing error. The given case instead establishes:The mismatch was intercepted before reaching the patient.

A system hazard without a completed error

A hazard increases risk even before a specific error occurs. The given case instead establishes:The mismatch was intercepted before reaching the patient.

Reference basis: PTCE Content Outline effective January6,2026. These are original learning questions, not questions reproduced from the references.

QUESTION 08Order Entry and Processing

Units and dose calculations

Fictional training order: one dose contains500mg. The matched tablet contains250mg per tablet. How many tablets provide the stated dose?

  1. 500
  2. 2
  3. 1/2
  4. 250

Answer: 2

  1. Divide the ordered milligrams by milligrams per tablet; mg units cancel.
  2. Use the explicit supplied relationship, keeping the requested unit attached to the calculation.
  3. The result is2tablets. Check by reversing the operation against the given quantity. This is a fictional training calculation, not an instruction to prescribe or alter a dose.
Compare the other answer choices
250

Use the tablet strength as the tablet count.

500

Use the milligram dose as a tablet count.

1/2

Reverse the dose-to-strength division.

Reference basis: PTCE Content Outline effective January6,2026. These are original learning questions, not questions reproduced from the references.

QUESTION 09Medications

Warnings, storage, and product dates

A patient names a medicine and describes facial swelling after taking it. What information-handling principle applies?

  1. A side-effect report still needs appropriate review
  2. A reported substance and reaction need pharmacist review
  3. A prior tolerance report does not erase a new allergy concern
  4. No allergy information has been established

Answer: A reported substance and reaction need pharmacist review

  1. The reported substance and reaction warrant prompt pharmacist attention.
  2. A possible allergy should be documented and escalated through the clinical review process.
  3. The matching choice isA reported substance and reaction need pharmacist review. Compare the actual requested field or workflow stage with each alternative rather than choosing a generally related statement.
Compare the other answer choices
No allergy information has been established

An unanswered or unavailable allergy field is not confirmation of no allergies. The given case instead establishes:The reported substance and reaction warrant prompt pharmacist attention.

A side-effect report still needs appropriate review

A symptom report should not be dismissed or clinically classified beyond the technician role. The given case instead establishes:The reported substance and reaction warrant prompt pharmacist attention.

A prior tolerance report does not erase a new allergy concern

New reports need assessment even when the person previously used a product. The given case instead establishes:The reported substance and reaction warrant prompt pharmacist attention.

Reference basis: PTCE Content Outline effective January6,2026. These are original learning questions, not questions reproduced from the references.

QUESTION 10Patient Safety and Quality Assurance

Clean work and unresolved discrepancies

Used gloves are removed before handling clean preparation supplies. Which hygiene step remains necessary?

  1. Use appropriate exposure-based PPE
  2. Perform hand hygiene as indicated
  3. Separate contaminated items from clean stock
  4. Use the approved surface and equipment process

Answer: Perform hand hygiene as indicated

  1. Gloves do not replace the indicated hand-hygiene step.
  2. Hand hygiene supports contamination prevention and is not replaced by gloves.
  3. The matching choice isPerform hand hygiene as indicated. Compare the actual requested field or workflow stage with each alternative rather than choosing a generally related statement.
Compare the other answer choices
Use the approved surface and equipment process

Cleaning methods depend on the equipment and contamination. The given case instead establishes:Gloves do not replace the indicated hand-hygiene step.

Separate contaminated items from clean stock

Separation helps prevent transfer from contaminated material to clean supplies. The given case instead establishes:Gloves do not replace the indicated hand-hygiene step.

Use appropriate exposure-based PPE

PPE should match the expected exposure rather than habit alone. The given case instead establishes:Gloves do not replace the indicated hand-hygiene step.

Reference basis: PTCE Content Outline effective January6,2026. These are original learning questions, not questions reproduced from the references.

BUILD ON WHAT YOU NOTICED

Turn one question into a learning route

Start with the lesson linked to an unfamiliar topic, try a focused set in the practice studio, then return to the review cards. Your practice progress stays in this browser.

Scope, sources and review notes

Catalog scope record: . This records the saved content mapping, not a guarantee that every external rule is current.

  • Selected information-handling and workflow foundations, not complete medication or federal-law mastery.
  • Given product labels and training orders are fictional educational examples, not patient-specific treatment advice.
  • Current therapeutic class knowledge, broad drug-name recall and every state-law variation are not comprehensively covered.
  • Independent pharmacist educator review and learner calibration remain pending.
  • Foundation pilot, not full syllabus coverage or official simulation
  • Question variants are not independent question designs
  • Independent educator review pending
  • Evidence integrity and structure checks do not establish factual or audiovisual fidelity

Check the exam provider's current information for registration, test rules and official preparation materials. The exam guide collects the relevant official references.

OFFICIAL REFERENCEPTCE Content Outline effective January6,2026

Applicable PTCE2026 domains and weights35/18.75/23.75/22.50; task alignment, not validation of every example product.

OFFICIAL REFERENCEDEA Drug Scheduling reference

OxycodoneII,ketamineIII,alprazolamIV,pregabalinV examples; web-read reference; directcapture403 retained.

OFFICIAL REFERENCEFDA Recalls Background and Definitions

Recall class definitions and distinction from unclassified product concerns.